Tenon Medical Inc (TNON)
2.81
-0.49
(-14.85%)
USD |
NASDAQ |
Nov 14, 16:00
2.72
-0.09
(-3.20%)
After-Hours: 05:51
Tenon Medical Research and Development Expense (Quarterly): 0.708M for June 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.708M |
| March 31, 2024 | 0.669M |
| December 31, 2023 | 0.691M |
| September 30, 2023 | 0.737M |
| June 30, 2023 | 0.901M |
| March 31, 2023 | 0.834M |
| December 31, 2022 | 0.812M |
| Date | Value |
|---|---|
| September 30, 2022 | 0.797M |
| June 30, 2022 | 0.657M |
| March 31, 2022 | 0.562M |
| December 31, 2021 | 0.793M |
| September 30, 2021 | 0.601M |
| June 30, 2021 | 0.237M |
| March 31, 2021 | 0.087M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.087M
Minimum
Mar 2021
0.901M
Maximum
Jun 2023
0.649M
Average
0.6995M
Median
Research and Development Expense (Quarterly) Benchmarks
| Alphatec Holdings Inc | 20.36M |
| Perspective Therapeutics Inc | 9.275M |
| Retractable Technologies Inc | 0.1991M |
| Xtant Medical Holdings Inc | 0.636M |
| Catheter Precision Inc | 0.081M |